Diagnostic and prognostic implications of molecular status in Chinese adults with diffuse glioma: An observational study

Background and Aim: Mutations in isocitrate dehydrogenase (IDH), co-deletion of 1p and 19q, loss or expression of the transcription regulator ATRX, and mutations in telomerase reverse transcriptase (TERT) gene promoters are intimately linked with diffuse gliomas. We further explored the roles of the...

Full description

Bibliographic Details
Main Authors: Leiming Wang, Zhuo Li, Cuicui Liu, Liyan Zhang, Dandan Wang, Haijing Ge, Weiwei Xu, Yongjuan Fu, Yanning Cai, Dehong Lu, Yueshan Piao
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Glioma
Subjects:
Online Access:http://www.jglioma.com/article.asp?issn=2589-6113;year=2020;volume=3;issue=4;spage=168;epage=174;aulast=Wang
_version_ 1819315424790052864
author Leiming Wang
Zhuo Li
Cuicui Liu
Liyan Zhang
Dandan Wang
Haijing Ge
Weiwei Xu
Yongjuan Fu
Yanning Cai
Dehong Lu
Yueshan Piao
author_facet Leiming Wang
Zhuo Li
Cuicui Liu
Liyan Zhang
Dandan Wang
Haijing Ge
Weiwei Xu
Yongjuan Fu
Yanning Cai
Dehong Lu
Yueshan Piao
author_sort Leiming Wang
collection DOAJ
description Background and Aim: Mutations in isocitrate dehydrogenase (IDH), co-deletion of 1p and 19q, loss or expression of the transcription regulator ATRX, and mutations in telomerase reverse transcriptase (TERT) gene promoters are intimately linked with diffuse gliomas. We further explored the roles of the key molecules in adulthood diffuse gliomas and their prognosis. Materials and Methods: A total of 413 patients who underwent primary surgery between 2009 and 2015 at Xuanwu Hospital, Beijing, China, were included in this observational study. All specimens from the patients were fixed in 10% neutral buffered formalin and embedded in paraffin. The mutational status of IDH1/2 and the TERT promoter was determined using polymerase chain reaction-based direct sequencing. The assay for the 1p and 19q co-deletion was conducted using fluorescence in situ hybridization. Overall- and progression-free survival was calculated using the Kaplan–Meier method and the log-rank test. The study was approved by the Ethics Committee of Xuanwu Hospital, Capital Medical University, China (approval No. [2019]004) on May 22, 2019. Results: We found that tumors characterized by multiple lesions were predominantly free of IDH mutations (P < 0.001). Gliomas with IDH mutations arose more often in the frontal and insular lobes than in the other lobes (P < 0.001). Rates of IDH mutations were higher in patients who had seizures or were without discomfort than in those who had other clinical symptoms (P = 0.0003). Of 119 patients with complete molecular information according to the 2016 World Health Organization classification of central nervous system tumors, 5 had oligoastrocytomas that had multiple genotypes – IDH1 mutation, loss of ATRX expression, and 1p/19q co-deletion – but lacked TERT promoter mutations. Patients with seizures or without discomfort who had IDH mutations had better outcomes than did other patients (P < 0.001). Patients whose tumors had IDH and TERT promoter mutations had a better prognosis than did other patients (P < 0.001). Among patients whose tumors had wild-type IDH, those with loss of ATRX survived longer than did others (P = 0.005). Conclusions: The status of both ATRX and the TERT promoter can indicate the prognosis in patients with IDH wild-type gliomas. The diagnosis that is based on clinical symptoms, histologic findings, and molecular analysis should be implemented as the diagnostic standard for patients with oligoastrocytomas.
first_indexed 2024-12-24T09:59:54Z
format Article
id doaj.art-d7381adc93c94630aab2500bb9b9cde2
institution Directory Open Access Journal
issn 2589-6113
2589-6121
language English
last_indexed 2024-12-24T09:59:54Z
publishDate 2020-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Glioma
spelling doaj.art-d7381adc93c94630aab2500bb9b9cde22022-12-21T17:01:09ZengWolters Kluwer Medknow PublicationsGlioma2589-61132589-61212020-01-013416817410.4103/glioma.glioma_21_20Diagnostic and prognostic implications of molecular status in Chinese adults with diffuse glioma: An observational studyLeiming WangZhuo LiCuicui LiuLiyan ZhangDandan WangHaijing GeWeiwei XuYongjuan FuYanning CaiDehong LuYueshan PiaoBackground and Aim: Mutations in isocitrate dehydrogenase (IDH), co-deletion of 1p and 19q, loss or expression of the transcription regulator ATRX, and mutations in telomerase reverse transcriptase (TERT) gene promoters are intimately linked with diffuse gliomas. We further explored the roles of the key molecules in adulthood diffuse gliomas and their prognosis. Materials and Methods: A total of 413 patients who underwent primary surgery between 2009 and 2015 at Xuanwu Hospital, Beijing, China, were included in this observational study. All specimens from the patients were fixed in 10% neutral buffered formalin and embedded in paraffin. The mutational status of IDH1/2 and the TERT promoter was determined using polymerase chain reaction-based direct sequencing. The assay for the 1p and 19q co-deletion was conducted using fluorescence in situ hybridization. Overall- and progression-free survival was calculated using the Kaplan–Meier method and the log-rank test. The study was approved by the Ethics Committee of Xuanwu Hospital, Capital Medical University, China (approval No. [2019]004) on May 22, 2019. Results: We found that tumors characterized by multiple lesions were predominantly free of IDH mutations (P < 0.001). Gliomas with IDH mutations arose more often in the frontal and insular lobes than in the other lobes (P < 0.001). Rates of IDH mutations were higher in patients who had seizures or were without discomfort than in those who had other clinical symptoms (P = 0.0003). Of 119 patients with complete molecular information according to the 2016 World Health Organization classification of central nervous system tumors, 5 had oligoastrocytomas that had multiple genotypes – IDH1 mutation, loss of ATRX expression, and 1p/19q co-deletion – but lacked TERT promoter mutations. Patients with seizures or without discomfort who had IDH mutations had better outcomes than did other patients (P < 0.001). Patients whose tumors had IDH and TERT promoter mutations had a better prognosis than did other patients (P < 0.001). Among patients whose tumors had wild-type IDH, those with loss of ATRX survived longer than did others (P = 0.005). Conclusions: The status of both ATRX and the TERT promoter can indicate the prognosis in patients with IDH wild-type gliomas. The diagnosis that is based on clinical symptoms, histologic findings, and molecular analysis should be implemented as the diagnostic standard for patients with oligoastrocytomas.http://www.jglioma.com/article.asp?issn=2589-6113;year=2020;volume=3;issue=4;spage=168;epage=174;aulast=Wang1p/19q co-deletionatrxgliomaisocitrate dehydrogenasetelomerase reverse transcriptase gene
spellingShingle Leiming Wang
Zhuo Li
Cuicui Liu
Liyan Zhang
Dandan Wang
Haijing Ge
Weiwei Xu
Yongjuan Fu
Yanning Cai
Dehong Lu
Yueshan Piao
Diagnostic and prognostic implications of molecular status in Chinese adults with diffuse glioma: An observational study
Glioma
1p/19q co-deletion
atrx
glioma
isocitrate dehydrogenase
telomerase reverse transcriptase gene
title Diagnostic and prognostic implications of molecular status in Chinese adults with diffuse glioma: An observational study
title_full Diagnostic and prognostic implications of molecular status in Chinese adults with diffuse glioma: An observational study
title_fullStr Diagnostic and prognostic implications of molecular status in Chinese adults with diffuse glioma: An observational study
title_full_unstemmed Diagnostic and prognostic implications of molecular status in Chinese adults with diffuse glioma: An observational study
title_short Diagnostic and prognostic implications of molecular status in Chinese adults with diffuse glioma: An observational study
title_sort diagnostic and prognostic implications of molecular status in chinese adults with diffuse glioma an observational study
topic 1p/19q co-deletion
atrx
glioma
isocitrate dehydrogenase
telomerase reverse transcriptase gene
url http://www.jglioma.com/article.asp?issn=2589-6113;year=2020;volume=3;issue=4;spage=168;epage=174;aulast=Wang
work_keys_str_mv AT leimingwang diagnosticandprognosticimplicationsofmolecularstatusinchineseadultswithdiffusegliomaanobservationalstudy
AT zhuoli diagnosticandprognosticimplicationsofmolecularstatusinchineseadultswithdiffusegliomaanobservationalstudy
AT cuicuiliu diagnosticandprognosticimplicationsofmolecularstatusinchineseadultswithdiffusegliomaanobservationalstudy
AT liyanzhang diagnosticandprognosticimplicationsofmolecularstatusinchineseadultswithdiffusegliomaanobservationalstudy
AT dandanwang diagnosticandprognosticimplicationsofmolecularstatusinchineseadultswithdiffusegliomaanobservationalstudy
AT haijingge diagnosticandprognosticimplicationsofmolecularstatusinchineseadultswithdiffusegliomaanobservationalstudy
AT weiweixu diagnosticandprognosticimplicationsofmolecularstatusinchineseadultswithdiffusegliomaanobservationalstudy
AT yongjuanfu diagnosticandprognosticimplicationsofmolecularstatusinchineseadultswithdiffusegliomaanobservationalstudy
AT yanningcai diagnosticandprognosticimplicationsofmolecularstatusinchineseadultswithdiffusegliomaanobservationalstudy
AT dehonglu diagnosticandprognosticimplicationsofmolecularstatusinchineseadultswithdiffusegliomaanobservationalstudy
AT yueshanpiao diagnosticandprognosticimplicationsofmolecularstatusinchineseadultswithdiffusegliomaanobservationalstudy